Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C3H7NO2 |
| Molecular Weight | 89.0932 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N)C(O)=O
InChI
InChIKey=QNAYBMKLOCPYGJ-UHFFFAOYSA-N
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)
| Molecular Formula | C3H7NO2 |
| Molecular Weight | 89.0932 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation. | 2001-05-18 |
|
| An intrahelical salt bridge within the trigger site stabilizes the GCN4 leucine zipper. | 2001-04-27 |
|
| Different usage of the glycosaminoglycan attachment sites of biglycan. | 2001-04-20 |
|
| Characterization of a phospholipase C beta 2-binding site near the amino-terminal coiled-coil of G protein beta gamma subunits. | 2001-04-06 |
|
| Disruption of an active site hydrogen bond converts human heme oxygenase-1 into a peroxidase. | 2001-04-06 |
|
| The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. | 2001-04-06 |
|
| Interacting fidelity defects in the replicative DNA polymerase of bacteriophage RB69. | 2001-03-30 |
|
| Construction of a high affinity zinc binding site in the metabotropic glutamate receptor mGluR1: noncompetitive antagonism originating from the amino-terminal domain of a family C G-protein-coupled receptor. | 2001-03-30 |
|
| Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanism. | 2001-03-30 |
|
| Scanning mutagenesis reveals roles for helix n of the bacteriophage T7 RNA polymerase thumb subdomain in transcription complex stability, pausing, and termination. | 2001-03-30 |
|
| Role of two histidines in the (6-4) photolyase reaction. | 2001-03-30 |
|
| Hydrogen exchange nuclear magnetic resonance spectroscopy mapping of antibody epitopes on the house dust mite allergen Der p 2. | 2001-03-23 |
|
| The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains. | 2001-03-23 |
|
| Roles for the C-terminal region of sigma 54 in transcriptional silencing and DNA binding. | 2001-03-23 |
|
| Requirements and effects of palmitoylation of rat PLD1. | 2001-03-23 |
|
| Functional rescue of the nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutants G185C and R202C by a second site suppressor mutation. | 2001-03-16 |
|
| The regulation of type 7 adenylyl cyclase by its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD. | 2001-03-16 |
|
| Regulation of ROMK1 channels by protein-tyrosine kinase and -tyrosine phosphatase. | 2001-03-09 |
|
| Mutagenic analysis of functional residues in putative substrate-binding site and acidic domains of vacuolar H+-pyrophosphatase. | 2001-03-09 |
|
| Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). | 2001-01-26 |
|
| The PD...(D/E)XK motif in restriction enzymes: a link between function and conformation. | 2001-01-16 |
|
| Substituting leucine for alanine-86 in the tether region of the iron-sulfur protein of the cytochrome bc1 complex affects the mobility of the [2Fe2S] domain. | 2001-01-16 |
|
| Short, solubilized polyalanines are conformational chameleons: exceptionally helical if N- and C-capped with helix stabilizers, weakly to moderately helical if capped with rigid spacers. | 2001-01-16 |
|
| Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis. | 2001-01-12 |
|
| Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. | 2001-01-09 |
|
| Vitamin B12 and hepatic enzyme serum levels correlate in male alcohol-dependent patients. | 2001-01-05 |
|
| The role of nitric oxide in bradycardia of rats with obstructive cholestasis. | 2001-01-05 |
|
| Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chirality. | 2001-01-01 |
|
| Ligand binding to integrin alpha(v)beta(3) requires tyrosine 178 in the alpha(v) subunit. | 2001-01-01 |
|
| Microdialysis study of amino acid neurotransmitters in the spinal dorsal horn of patients undergoing microsurgical dorsal root entry zone lesioning. Technical note. | 2001-01 |
|
| Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. | 2001-01 |
|
| Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis. | 2001-01 |
|
| Reactivation of viral replication after liver resection in patients infected with hepatitis B virus. | 2001-01 |
|
| Oral glycoprotein IIb/IIIa antagonists in coronary artery disease. | 2001-01 |
|
| Low-dose IGF-I has no selective advantage over insulin in regulating glucose metabolism in hyperglycemic depancreatized dogs. | 2001-01 |
|
| Neutrophils, not complement, mediate the mortality of experimental hemorrhagic pancreatitis. | 2001-01 |
|
| Viral markers and use of factor products among Finnish patients with bleeding disorders. | 2001-01 |
|
| Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function. | 2001-01 |
|
| Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon. | 2001-01 |
|
| High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. | 2001-01 |
|
| Chronic hepatitis C in different populations: similar patterns of alanine aminotransferase alteration characterize similar clinical subgroups. | 2001-01 |
|
| Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. | 2001-01 |
|
| Fas/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus-mediated gene transfer. | 2001-01 |
|
| Hepatic neovascularization after partial portal vein ligation: novel mechanism of chronic regulation of blood flow. | 2001-01 |
|
| Engineering the active site of ascorbate peroxidase. | 2001-01 |
|
| Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. | 2001-01 |
|
| Epidermal growth factor reduces multiorgan failure induced by thioacetamide. | 2001-01 |
|
| Zaltoprofen prevents carbon tetrachloride-induced reduction of body weight in rats. | 2001-01 |
|
| Novel mutations in the GALK1 gene in patients with galactokinase deficiency. | 2001 |
|
| Is the Ala138Gly alteration of MEFV gene important for amyloidosis? | 2001 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:26 GMT 2025
by
admin
on
Mon Mar 31 17:34:26 GMT 2025
|
| Record UNII |
1FU7983T0U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 172.540
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
||
|
JECFA EVALUATION |
DL-ALANINE
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
||
|
NCI_THESAURUS |
C29596
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1FU7983T0U
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | |||
|
602
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | |||
|
302-72-7
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | |||
|
DTXSID6031255
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | |||
|
1546161
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | RxNorm | ||
|
C61731
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | |||
|
1425
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | |||
|
7602
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | |||
|
4306
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | |||
|
m1467
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY | Merck Index | ||
|
206-126-4
Created by
admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |